ReShape Lifesciences Q4 Earnings Highlights and Business Update Conference Transcript
AinvestThursday, Apr 10, 2025 5:56 pm ET
1min read ReShape Lifesciences Inc. (RSLS) reported financial highlights and strategic business update. The company's President and CEO, Paul Hickey, discussed the company's activities and strategic updates, while CFO Tom Stankovich reviewed the financial performance. The company's forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that could differ materially from actual results. ReShape Lifesciences' stock is listed on NASDAQ under the symbol RSLS.
View Source
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
_183e5bc31749756677125.jpeg)
